
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
RNF10 CRISPR/Cas9 KO Plasmid (h) | sc-409761 | 20 µg | $397.00 |
RNF10 encodes a RING-type zinc finger protein implicated in ubiquitin-dependent regulation of protein stability and signaling output. Through E3 ligase-associated processes, RNF10 has been linked to control of transcriptional programs, receptor-mediated signaling, and proteostasis pathways that influence cell growth and differentiation. Altered RNF10 expression or regulation has been reported in contexts involving neural and cardiovascular biology and is studied for its potential contribution to dysregulated cellular homeostasis in disease. RNF10 is therefore relevant for investigating how ubiquitin-mediated remodeling of signaling networks affects gene expression and cell fate decisions.
RNF10 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the RNF10 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the RNF10 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the RNF10 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish RNF10 protein expression.
This CRISPR knockout system enables efficient generation of RNF10-deficient cell models for investigation of RNF10 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.